Correlation Between Exagen and MACOM Technology

Can any of the company-specific risk be diversified away by investing in both Exagen and MACOM Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exagen and MACOM Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Exagen Inc and MACOM Technology Solutions, you can compare the effects of market volatilities on Exagen and MACOM Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exagen with a short position of MACOM Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exagen and MACOM Technology.

Diversification Opportunities for Exagen and MACOM Technology

0.75

Correlation Coefficient

Exagen  MACOM Technology

Poor diversification

The 3 months correlation between Exagen and MACOM is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Exagen Inc and MACOM Technology Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MACOM Technology Sol and Exagen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exagen Inc are associated (or correlated) with MACOM Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MACOM Technology Sol has no effect on the direction of Exagen i.e., Exagen and MACOM Technology go up and down completely randomly.

Pair Corralation between Exagen and MACOM Technology

Considering the 90-day investment horizon Exagen Inc is expected to under-perform the MACOM Technology. In addition to that, Exagen is 4.99 times more volatile than MACOM Technology Solutions. It trades about -0.17 of its total potential returns per unit of risk. MACOM Technology Solutions is currently generating about -0.21 per unit of volatility. If you would invest  14,103  in MACOM Technology Solutions on October 4, 2024 and sell it today you would lose (1,160) from holding MACOM Technology Solutions or give up 8.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Exagen Inc  vs.  MACOM Technology Solutions

Exagen Inc

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.

MACOM Technology Sol

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in MACOM Technology Solutions are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent basic indicators, MACOM Technology demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Exagen and MACOM Technology

The main advantage of trading using opposite Exagen and MACOM Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exagen position performs unexpectedly, MACOM Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MACOM Technology will offset losses from the drop in MACOM Technology's long position.

The idea behind Exagen Inc and MACOM Technology Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.